Search Results
Facet (Page)
Refine Your Search
Audiences
Content Formats
Divisions
Educational Resources
BRCA1 and BRCA2 are the first two genes found to be associated with inherited forms of breast cancer.
… BRCA1/BRCA2 … BRCA1 and BRCA2 are the first two genes found to be … Mutation, Genes, DNA Repair, Family Health History … BRCA1 and BRCA2 are the first two genes found to be … cancer and ovarian cancer. People with mutations in either BRCA1 or BRCA2 have a much higher risk for developing breast, …
Talking Glossary
BRCA1 y BRCA2 son los dos primeros genes que se identificaron como asociados a tipos hereditarios del cáncer de mama y de ovario. Las personas con mutaciones en BRCA1 o BRCA2 tienen un riesgo mucho más alto de desarrollar cáncer de mama, de ovario u otros tipos de cáncer en comparación con las personas que no tienen mutaciones en estos genes.
… BRCA1/BRCA2 … BRCA1 y BRCA2 son los dos primeros genes que se identificaron … cáncer de mama y de ovario. Las personas con mutaciones en BRCA1 o BRCA2 tienen un riesgo mucho más alto de desarrollar … las personas que no tienen mutaciones en estos genes. … BRCA1 and BRCA2 are the first two genes found to be …
Genetic Disorders
Breast cancer is the second most common cancer in women after skin cancer.
… In 1994, the first gene associated with breast cancer - BRCA1 (for BReast CAncer1) was identified on chromosome 17. A … 13. When individuals carry a mutated form of either BRCA1 or BRCA2, they have an increased risk of developing … at some point in their lives. Children of parents with a BRCA1 or BRCA2 mutation have a 50 percent chance of …
Policy Issues
In June 2013, the Supreme Court determined that DNA in its natural form cannot be patented.
… suit challenged the constitutionality and validity of the BRCA1 and BRCA2 gene patents. Myriad Genetics had been … plaintiffs  and against Myriad Genetics, finding that the BRCA1 and BRCA2 genes were products of nature and therefore …
Genomics and Medicine
Starting in 2019, the American Journal of Human Genetics has published an annual feature identifying ten key advances in applying genomic information to clinical care that were reported in the previous 12 months of published literature. The Genomic Medicine Working Group has authored these reviews, based on its broader effort to identify notable accomplishments in genomic medicine on a monthly basis. From this larger set of published accomplishments, the working group has continued to select ten papers annually to be highlighted as the most significant.
… Associated with Sudden Death What We’re Missing: Most BRCA1 and BRCA2 Variant Carriers Are Undetected Cascade …
Policy Issues
En una decisión histórica en junio de 2013, el Tribunal Supremo determinó que el ADN en su forma natural no puede ser patentado.
… la constitucionalidad y validez de las patentes génicas de BRCA1 y BRCA2. Myriad Genetics habÃa sido especialmente … en contra de Myriad Genetics, determinando que los genes BRCA1 y BRCA2 eran productos de la naturaleza y, por ende, no …
Health
Un puntaje de riesgo poligénico es una forma en que las personas pueden conocer cuál es su riesgo de desarrollar una enfermedad, según el número total de variantes genómicas relacionadas con la enfermedad.
… una enfermedad. Las mujeres portadoras de la mutación BRCA1 tienen un riesgo absoluto de 60 a 80% de sufrir cáncer …
About NHGRI
A timeline of notable events in the history of the National Human Genome Research Institute.
… that three specific alterations in the breast cancer genes BRCA1 and BRCA2 are associated with an increased risk of …